Episode Details

Back to Episodes
MedPal AI Launches New Health — £1.3m Push Into GLP-1

MedPal AI Launches New Health — £1.3m Push Into GLP-1

Episode 2404 Published 4 months, 1 week ago
Description
MedPal AI (AIM: MPAL) launches New Health, a standalone GLP-1 sub-brand backed by £1.3 million of marketing, ahead of expected UK approval of Novo Nordisk’s oral Wegovy. CEO Jason Drummond on the strategy, the market, and the unit economics behind it.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us